Head to head for first-timers
CoreAge Rx vs Spry
CoreAge Rx and Spry both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxSpry
Rank #90 for first-timers · Grade C
Mama-Match
Best for: Moms who like seeing named founders behind a brand and will read the 'FDA Approved' badge skeptically rather than at face value.
Visit SpryThe verdict for a first step
CoreAge Rx edges out Spry on the Mama-Match Score, 94 to 55 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Spry is still a genuine option — $199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. Its pricing only surfaces from the site's own compiled JavaScript rather than the visible marketing page, which is how it was confirmed for this review. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Spry |
|---|---|---|
| Mama-Match Score | 94/100 · A | 55/100 · C |
| Overall rank | #1 | #90 |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $299/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Spry
Rank #90 · Grade C
What we like
- Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
- No contracts required, with a stated ~24-hour nurse practitioner review of intake
- Also offers three longevity peptides if that's of interest beyond weight loss
The caveats
- Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
- No pharmacy named, and no state-availability list found
- Site is a client-rendered app, which made its own pricing harder to verify than a normal marketing page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Spry with the other providers we review for women.
Or browse the full comparison hub.